Ignite Creation Date:
2024-05-05 @ 12:04 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00234026
Status:
COMPLETED
Last Update Posted:
2012-06-05
First Post:
2005-10-05
Brief Title:
Gemcitabine in Treating Patients With Newly Diagnosed Relapsed or Chemotherapy-Resistant Mantle Cell Lymphoma
Sponsor:
Swiss Group for Clinical Cancer Research
Organization:
Swiss Group for Clinical Cancer Research
Organization Data
Organization:
Swiss Group for Clinical Cancer Research
Class:
OTHER
Study ID:
SAKK 3603
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Swiss Group for Clinical Cancer Research
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None